|
4 Companies |
|
1 Product |
|
1 Product |
|
4 Mechanisms of Action |
|
0 Trials |
|
6 News |
|
- piperacillin sodium/tazobactam sodium / Generic mfg., metronidazole oral / Generic mfg.
Trial primary completion date: Non-operative Management of Pediatric Appendicitis With an Appendicoltih (clinicaltrials.gov) - Aug 19, 2016
P=N/A, N=14, Terminated, Sponsor: Peter Minneci
Trial primary completion date: Jul 2016 --> Jul 2015
- piperacillin sodium/tazobactam sodium / Generic mfg., metronidazole oral / Generic mfg.
Enrollment change, Trial termination: Non-operative Management of Pediatric Appendicitis With an Appendicoltih (clinicaltrials.gov) - Aug 17, 2015
P=N/A, N=14, Terminated, Sponsor: Peter Minneci
Trial primary completion date: Jul 2016 --> Jul 2015 N=150 --> 14 | Recruiting --> Terminated; High failure rate
- piperacillin sodium/tazobactam sodium / Generic mfg., metronidazole oral / Generic mfg.
Trial primary completion date: Non-operative Management of Pediatric Appendicitis With an Appendicoltih (clinicaltrials.gov) - Feb 3, 2015
P=N/A, N=150, Recruiting, Sponsor: Peter Minneci
N=150 --> 14 | Recruiting --> Terminated; High failure rate Trial primary completion date: Jul 2015 --> Jul 2016
- metronidazole oral / Generic mfg.
Clinical: Non-operative Management of Pediatric Appendicitis With an Appendicoltih (clinicaltrials.gov) - Jul 14, 2014
P=N/A, N=150, Recruiting, Sponsor: Peter Minneci
- | Movicol (AJG555) / Mochida, Eisai
New P4 trial: Efficacy and Tolerability of PEG-only Laxative for Fecal Impaction and Chronic Constipation in Children (clinicaltrials.gov) - May 3, 2012
P4, N=96, Completed, Sponsor: Azienda Policlinico Umberto I